Francesca Valcamonico

488 total citations
43 papers, 317 citations indexed

About

Francesca Valcamonico is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Francesca Valcamonico has authored 43 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Francesca Valcamonico's work include Prostate Cancer Treatment and Research (13 papers), Bone health and treatments (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Francesca Valcamonico is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Bone health and treatments (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Francesca Valcamonico collaborates with scholars based in Italy, Canada and United States. Francesca Valcamonico's co-authors include Vito Amoroso, Vittorio Ferrari, Giovanni Marini, Salvatore Grisanti, P. Marpicati, Edda Simoncini, G. Rangoni, Lucia Vassalli, Alfredo Berruti and Luca Triggiani and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Francesca Valcamonico

39 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Valcamonico Italy 10 126 122 88 63 40 43 317
Yuichi Terado Japan 12 106 0.8× 126 1.0× 104 1.2× 32 0.5× 72 1.8× 27 367
Khoon Leong Chuah Singapore 9 118 0.9× 108 0.9× 55 0.6× 52 0.8× 90 2.3× 30 349
Eugene Tan United States 9 103 0.8× 83 0.7× 140 1.6× 34 0.5× 36 0.9× 20 413
Feiying Gu China 10 106 0.8× 94 0.8× 133 1.5× 55 0.9× 51 1.3× 11 316
Yasutaka Watanabe Japan 10 115 0.9× 159 1.3× 104 1.2× 32 0.5× 47 1.2× 39 376
Shumpei Matsuura Japan 11 154 1.2× 119 1.0× 113 1.3× 67 1.1× 41 1.0× 19 490
Alistair Cook Australia 13 310 2.5× 254 2.1× 110 1.3× 34 0.5× 36 0.9× 30 691
Michelle Ferreira United States 6 383 3.0× 92 0.8× 80 0.9× 46 0.7× 20 0.5× 13 570

Countries citing papers authored by Francesca Valcamonico

Since Specialization
Citations

This map shows the geographic impact of Francesca Valcamonico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Valcamonico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Valcamonico more than expected).

Fields of papers citing papers by Francesca Valcamonico

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Valcamonico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Valcamonico. The network helps show where Francesca Valcamonico may publish in the future.

Co-authorship network of co-authors of Francesca Valcamonico

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Valcamonico. A scholar is included among the top collaborators of Francesca Valcamonico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Valcamonico. Francesca Valcamonico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Volta, Alberto Dalla, Francesca Valcamonico, Andrea Zivi, et al.. (2025). Addition of zoledronic acid to enzalutamide and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: the randomized phase II BONENZA trial. Prostate Cancer and Prostatic Diseases. 29(1). 116–123. 1 indexed citations
2.
Rossini, Elisa, Andrea Abate, Giovanni Ribaudo, et al.. (2024). The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study. Cells. 13(5). 368–368. 4 indexed citations
3.
4.
5.
Volta, Alberto Dalla, Andrea Delbarba, Francesca Valcamonico, et al.. (2023). Gonadal Function in Male Patients With Metastatic Renal Cell Cancer Treated With Sunitinib. In Vivo. 37(1). 410–416. 2 indexed citations
6.
Volta, Alberto Dalla, Deborah Cosentini, Francesca Valcamonico, et al.. (2023). Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients. Current Oncology Reports. 25(10). 1141–1152. 7 indexed citations
7.
Volta, Alberto Dalla, Carlotta Palumbo, Stefania Zamboni, et al.. (2023). Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health—the BLADE study. Journal of Endocrinological Investigation. 47(2). 335–343. 7 indexed citations
8.
Volta, Alberto Dalla, Luisa Bercich, Simona Fisogni, et al.. (2022). Case Report: 18F-PSMA PET/CT Scan in Castration Resistant Prostate Cancer With Aggressive Neuroendocrine Differentiation. Frontiers in Oncology. 12. 937713–937713. 6 indexed citations
9.
Palumbo, Carlotta, Alessandro Antonelli, Luca Triggiani, et al.. (2021). Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study. Prostate Cancer and Prostatic Diseases. 24(3). 852–859. 9 indexed citations
10.
Volta, Alberto Dalla, Francesca Valcamonico, Stefania Zamboni, et al.. (2020). Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients?. Minerva Urologica e Nefrologica. 72(6). 778–779. 4 indexed citations
11.
Volta, Alberto Dalla, Francesca Valcamonico, Rebecca Pedersini, et al.. (2020). The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures. Frontiers in Oncology. 10. 1574–1574. 3 indexed citations
12.
Bardoscia, Lilia, Luca Triggiani, Marco Sandri, et al.. (2020). Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group. World Journal of Urology. 39(4). 1161–1170. 6 indexed citations
13.
Fragni, Martina, Francesca Valcamonico, Elisa Rossini, et al.. (2017). Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity. Pharmacology. 100(5-6). 261–268. 13 indexed citations
14.
Basso, Umberto, Marco Maruzzo, Franco Morelli, et al.. (2015). Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey. Clinical Genitourinary Cancer. 14(2). e161–e169. 12 indexed citations
15.
Valcamonico, Francesca, Vittorio Ferrari, Vito Amoroso, et al.. (2008). Long-lasting successful cerebral response with sorafenib in advanced renal cell carcinoma. Journal of Neuro-Oncology. 91(1). 47–50. 32 indexed citations
16.
Amoroso, Vito, Salvatore Grisanti, Francesca Valcamonico, et al.. (2007). Osteoblastic flare in a patient with advanced gastric cancer after treatment with pemetrexed and oxaliplatin: implications for response assessment with RECIST criteria. BMC Cancer. 7(1). 94–94. 17 indexed citations
17.
Rossi, Elisa, Edda Simoncini, Francesca Valcamonico, et al.. (2006). Different Expression of HER2/neu Oncogene in Breast Carcinoma and in Liver Metastasis. Description of a Case. Tumori Journal. 92(6). 536–539. 1 indexed citations
18.
Ferrari, Vittorio, Francesca Valcamonico, Vito Amoroso, et al.. (2005). FAFOXIRI: A phase II trial of an alternating regimen of irinotecan/5-fluoruracil/folinic acid and oxaliplatin/5-fluoruracil/folinic acid in metastatic colorectal cancer. Journal of Clinical Oncology. 23(16_suppl). 3660–3660. 5 indexed citations
19.
Ferrari, Vittorio, Vito Amoroso, Francesca Valcamonico, et al.. (2004). Epirubicin, Cisplatin, and Raltitrexed in Patients With Advanced Gastric and Hepatobiliary Carcinoma. American Journal of Clinical Oncology. 27(5). 445–448. 8 indexed citations
20.
Valcamonico, Francesca, Vittorio Ferrari, Edda Simoncini, et al.. (2004). Paraneoplastic Nephrotic Syndrome in Advanced Breast Cancer Patient. A Case Report. Tumori Journal. 90(1). 154–156. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuichi Terado Breakdown of academic impact, for papers by Khoon Leong Chuah Breakdown of academic impact, for papers by Eugene Tan Breakdown of academic impact, for papers by Feiying Gu Breakdown of academic impact, for papers by Yasutaka Watanabe Breakdown of academic impact, for papers by Shumpei Matsuura Breakdown of academic impact, for papers by Alistair Cook Breakdown of academic impact, for papers by Michelle Ferreira
Rankless by CCL
2026